Roland Bammer

Roland Bammer is a Professor in the Department of Radiology & Radiological Sciences at Monash University’s Faculty of Medicine. He is actively engaged in cutting-edge research in neuroimaging, cerebrovascular diseases, and the application of artificial intelligence in medical imaging. His work bridges clinical radiology with advanced computational techniques to improve diagnostic accuracy and patient outcomes.

His primary research interests include Medical Imaging, Neuroimaging, MRI and DTI techniques, perivascular space analysis (e.g., ALPS index), dementia and neurodegenerative disorders, and AI-driven image segmentation. He also investigates the clinical and operational impacts of iodinated contrast media shortages, contributing to policy and hospital-level decision-making.

The recent publications highlight a strong trend toward integrating artificial intelligence with clinical imaging to enhance semi-supervised segmentation and optimize diagnostic workflows. His work spans both technical innovation in image processing and practical challenges in radiology supply chains, reflecting a dual focus on computational advancement and healthcare systems resilience.

• Primary Chief Investigator, PREEMPT Project: Combining Novel Imaging Biomarkers with AI-Accelerated Diagnosis for cSDH treatment (2022–2026)
• Chief Investigator, CREEDD: Centre of Research Excellence in Enhanced Dementia Diagnosis (2022–2027)
• Primary Chief Investigator, Harnessing Imaging and IT Strategies in Cerebrovascular Diseases (2021–2025)

These projects are supported by significant research grants and involve multidisciplinary collaboration across neurology, radiology, data science, and public health. While no formal students are listed, his role as a chief investigator suggests mentorship of junior researchers and PhD candidates within these large-scale initiatives.

Roland Bammer is affiliated with a dynamic research environment focused on advancing neuroimaging technologies and improving diagnostic pathways in dementia and stroke-related conditions. His team collaborates extensively with clinical and technical experts both nationally and internationally, contributing to a robust network in medical imaging innovation.